Clinical data from the SUSTAIN trials and regulatory assessments show that: Gastrointestinal symptoms are most common during the early weeks of treatment Symptoms often occur or worsen transiently after each dose increase Most patients experience improvement over time with continued treatment A small percentage of patients discontinue treatment due to persistent gastrointestinal symptoms, with rates varying by dose Individual variation is considerable some patients experience minimal nausea that resolves within days, whilst others may have symptoms lasting several weeks or longer
95% CI, 0.6-1.13) and those not using a GLP-1 (HR = 0.89
[DOI] [PMC free article] [PubMed] [Google Scholar] 5.Landgraf R, Aberle J, Birkenfeld AL, et al
(Results Timeline Explained) Find out how long retatrutide takes to work, when results begin, and how to maximise fat loss with the right dosing and lifestyle habits
Start your intake How Tirzepatide Works After Bariatric Surgery Tirzepatide activates two hormone pathways that regulate hunger and blood sugar: the glucagon-like peptide-1 receptor and the glucose-dependent insulinotropic polypeptide receptor
